Piqur Therapeutics piqur.com


Public list: BIO 2016 (619) Pharma Startups (4733) Cancer Therapeutics (1136)

PIQUR is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition. PIQUR's pipeline originates from one of the most promising research areas in oncology. While mTOR is a clinically validated drug target, PI3K inhibition achieved proof of concept status in clinical phase IIb.

PIQUR is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition. PIQUR's pipeline originates from one of the most promising research areas in oncology. While mTOR...Show all

Company (Alive / Active)

Phone: +41 61 633 29 29

Fax:

Hochbergerstrasse 60C

Basel, CH-4057
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Piqur Therapeutics $19M Jul 20, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Piqur Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Versant VenturesVenture CapitalSan Francisco, California, United StatesSeries A - II, Series A
Undisclosed InvestorsOtherSeries A - II, Series A, Seed - II, Seed
Swiss Commission of Technology and InnovationGovernmentBern, SwitzerlandSeed
See all 3 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Conformationally restricted p13k and mtor inhibitors Oct 03, 2014 Jan 31, 2017 Patent
Novel manufacturing process for triazine, pyrimidine and pyridine derivatives Apr 20, 2015 Application